Oral Sabizabulin Demonstrates Mortality Reduction in High-Risk COVID-19 Patients
Treatment with oral Sabizabulin results in a significant 24.9% absolute reduction in deaths among hospitalized adults at high risk for severe COVID-19, highlighting its potential as a therapeutic option in combating the pandemic.
March 2023
FDA Recommends Modification of Vaccines to Include Omicron BA 4/5 Component
The FDA advises the inclusion of an Omicron BA 4/5 spike protein component in COVID-19 vaccines, prompting efforts to develop modified vaccine formulations to enhance protection against emerging variants of concern.
March 2023
Real-Time Monitoring Urged for Aerosol-Generating Dental Procedures Amid COVID-19
Experts emphasize the importance of real-time monitoring of aerosol-generating dental procedures to mitigate the risk of viral transmission to both dental staff and patients, highlighting the potential role of such particles in COVID-19 spread within dental settings.
March 2023
Unveiling the Leading Causes of Death During the COVID-19 Pandemic in the US
An analysis reveals the primary causes of death during the COVID-19 pandemic in the US, shedding light on the disease burden and mortality trends from March 2020 to October 2021, informing public health strategies and resource allocation efforts.
March 2023
